Article

ForbesForbes on 2024-03-27 11:26

Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime Soon

Experts told Forbes incumbents Novo Nordisk and Eli Lilly are unlikely to cede much ground to rival weight loss drugs eying their dominant positions, ...

Related news